Mirae Asset Global Etfs Holdings Ltd. Procept Bio Robotics Corp Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 638,550 shares of PRCT stock, worth $46.3 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
638,550
Previous 683,733
6.61%
Holding current value
$46.3 Million
Previous $41.8 Million
22.47%
% of portfolio
0.12%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding PRCT
# of Institutions
272Shares Held
39.6MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$351 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$253 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$111 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$90.1 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$85.5 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.23B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...